Research progress in the animal models of Parkinson′s disease depression
-
-
-
[1] 谢明琦, 陈治池, 王彤彤, 等. 神经增生在神经性毒物诱导的帕金森病动物模型中的研究进展[J]. 解剖学报, 2017, 48(5): 610-616. https://www.cnki.com.cn/Article/CJFDTOTAL-JPXB201705019.htm [2] Sanjari Moghaddam H, Zare-Shahabadi A, Rahmani F, et al. Neurotransmission systems in Parkinson′s disease[J]. Rev Neurosci, 2017, 28(5): 509-536.
[3] D′Ostilio K, Garraux G. The network model of depression as a basis for new therapeutic strategies for treating major depressive disorder in parkinson's disease[J]. Front Hum Neurosci, 2016, 10: 161-167. http://www.ncbi.nlm.nih.gov/pubmed/27148016
[4] Svenningsson P, Palhagen S, Mathé A A. Neuropeptide Y and calcitonin gene-related peptide in cerebrospinal fluid in parkinson′s disease with comorbid depression versus patients with major depressive disorder[J]. Front Psychiatry, 2017, 8: 102-109. doi: 10.3389/fpsyt.2017.00102
[5] Pifl C, Schingnitz G, Hornykiewicz O. Effect of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey[J]. Neuroscience, 1991, 44(3): 591-605. doi: 10.1016/0306-4522(91)90080-8
[6] Zhang Q S, Heng Y, Mou Z, et al. Reassessment of subacute MPTP-treated mice as animal model of Parkinson′s disease[J]. Acta Pharmacol Sin, 2017, 38(10): 1317-1328. doi: 10.1038/aps.2017.49
[7] Borah A, Mohanakumar K P. Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats[J]. Cell Mol Neurobiol, 2007, 27(8): 985-996. doi: 10.1007/s10571-007-9213-6
[8] Zhang X Q, Song D, Gu L, et al. Decrease of gene expression of astrocytic 5-HT2B receptors parallels development of depressive phenotype in a mouse model of Parkinson's disease[J]. Front Cell Neurosci, 2015, 9: 388-395. http://old.med.wanfangdata.com.cn/viewHTMLEn/PeriodicalPaper_PM26500493.aspx
[9] Liu X J, Zhang L, Zhang Y F, et al. Echogenic alteration in the raphe nuclei measured by transcranial sonography in patients with Parkinson disease and depression[J]. Medicine (Baltimore), 2018, 97(50): e13524-e13531. doi: 10.1097/MD.0000000000013524
[10] Berg D, Supprian T, Hofmann E, et al. Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging[J]. J Neurol, 1999, 246(12): 1186-1193. doi: 10.1007/s004150050541
[11] Prinz A, Selesnew L M, Liss B, et al. Increased excitability in serotonin neurons in the dorsal raphe nucleus in the 6-OHDA mouse model of Parkinson's disease[J]. Exp Neurol, 2013, 248: 236-245. doi: 10.1016/j.expneurol.2013.06.015
[12] Shen K Z, Kozell L B, Johnson S W. Multiple conductances are modulated by 5-HT receptor subtypes in rat subthalamic nucleus neurons[J]. Neuroscience, 2007, 148(4): 996-1003. doi: 10.1016/j.neuroscience.2007.07.012
[13] Beyeler A, Kadiri N, Navailles S, et al. Stimulation of serotonin2C receptors elicits abnormal oral movements by acting on pathways other than the sensorimotor one in the rat basal ganglia[J]. Neuroscience, 2010, 169(1): 158-170. doi: 10.1016/j.neuroscience.2010.04.061
[14] Janakiraman U, Manivasagam T, Justin Thenmozhi A, et al. Chronic mild stress augments MPTP induced neurotoxicity in a murine model of Parkinson′s disease[J]. Physiol Behav, 2017, 173: 132-143. http://www.sciencedirect.com/science/article/pii/S0031938416308642
[15] 万仁玲, 潘绮, 安晓虹, 等. 抑郁症小鼠模型的神经免疫改变[J]. 解剖学报, 2018, 49(3): 281-287. https://www.cnki.com.cn/Article/CJFDTOTAL-JPXB201803002.htm [16] Pankova N B, Vetrilé L A, Basharova L A, et al. Immunization of rats with conjugates of dopamine and serotonin with bovine serum albumin prevents the development of experimental MPTP-induced depressive syndrome (electrophysiological parameters)[J]. Neurosci Behav Physiol, 2004, 34(2): 131-138. doi: 10.1023/B:NEAB.0000009207.38914.2b
[17] Vuckoviĉ M G, Wood R I, Holschneider D P, et al. Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse model of basal ganglia injury[J]. Neurobiol Dis, 2008, 32(2): 319-327. doi: 10.1016/j.nbd.2008.07.015
[18] Muñoz-Manchado A B, Villadiego J, Romo-Madero S, et al. Chronic and progressive Parkinson′s disease MPTP model in adult and aged mice[J]. J Neurochem, 2016, 136(2): 373-387. http://europepmc.org/abstract/MED/26500044
[19] Santiago R M, Barbieiro J, Lima M M, et al. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2010, 34(6): 1104-1114. http://europepmc.org/abstract/MED/20547199
[20] 邢红霞, 刘胜, 赵建华, 等. 帕金森病伴发抑郁大鼠模型的建立及其不同脑区内单胺类神经递质水平的变化[J]. 华中科技大学学报: 医学版, 2014, 43(3): 259-265. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYX201403004.htm [21] Taylor T N, Caudle W M, Shepherd K R, et al. Nonmotor symptoms of Parkinson′s disease revealed in an animal model with reduced monoamine storage capacity[J]. J Neurosci, 2009, 29(25): 8103-8113. http://hmg.oxfordjournals.org/cgi/ijlink?linkType=ABST&journalCode=jneuro&resid=29/25/8103
[22] 包和华, 李月峰, 严金川, 等. 抑郁大鼠模型建立的磁共振评价手段探索[J]. 中华脑科疾病与康复杂志: 电子版, 2013, 3(5): 320-324. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHNB201305009.htm [23] 朱彦, 王冬青, 李月峰, 等. 抑郁模型大鼠额叶及海马对脑脊液炎症因子敏感性的磁共振质子波谱研究[J]. 中华行为医学与脑科学杂志, 2013, 22(4): 303-305. [24] 朱长强. 复发性抑郁大鼠模型PET脑功能成像研究[D]. 北京: 中国人民解放军军事医学科学院, 2013. [25] Gerits A, Vanduffel W. Optogenetics in primates: a shining future[J]. Trends Genet, 2013, 29(7): 403-411. http://europepmc.org/abstract/med/23623742
[26] Treweek J B, Chan K Y, Flytzanis N C, et al. Whole-body tissue stabilization and selective extractions via tissue-hydrogel hybrids for high-resolution intact circuit mapping and phenotyping[J]. Nat Protoc, 2015, 10(11): 1860-1896.
计量
- 文章访问数: 163
- HTML全文浏览量: 134
- PDF下载量: 11
下载:
苏公网安备 32100302010246号
